Evaluation of Subchondroplasty™ for Defects Associated With Bone Marrow Lesions

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

70 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-03-26

Study Completion Date

2021-05-26

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Studying long-term changes in a sub-set of patients who undergo the Subchondroplasty procedure including changes in pain, function, and overall health.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Subchondroplasty Procedure in Patients With Bone Marrow Lesions

NCT03430219

Bone Marrow Lesions Bone Marrow Edema

COMPLETED

Subchondroplasty® Knee RCT

NCT03112200

Bone Marrow Edema Knee Pain Chronic Knee Osteoarthritis +2 more

COMPLETED NA

Evaluating the Effectiveness of Subchondroplasty for Treating Bone Marrow Lesions of the Knee

NCT03699046

Osteoarthritis, Knee Arthroscopy Musculoskeletal Disease +3 more

UNKNOWN NA

Outcomes Data of Bone Marrow Stem Cells to Treat Hip and Knee Osteoarthritis

NCT01601951

Hip and Knee Osteoarthritis

COMPLETED

Autologous Chondrocyte Implantation in the Patellofemoral Joint

NCT00212849

Chondrosis Patellar Articular Cartilage Lesions Trochlear Articular Cartilage Lesions

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study is designed as a prospective, consecutive series outcomes study. Patients presenting with knee pain associated with bone marrow lesions that meet the inclusion criteria will be eligible to undergo Subchondroplasty procedure. The subjects will be followed for twenty-four (24) months after surgery via office visits and will be contacted once per year for up to 5 years post-operatively and asked questions regarding their pain and functioning to further understand long-term outcomes.. Seventy (70), a ( minimum of sixty-two (62)) patients who meet the inclusion/exclusion criteria will be enrolled in the study. Up to 5 sites will participate in this study. The study is intended to provide an estimate of one-year and two-year clinical success with minimum bias and with sufficient statistical precision to permit meaningful comparison to commonly accepted two-year clinical success rates for currently available treatment alternatives. An improvement of 10 points on the Knee Injury and Osteoarthritis Outcome Score (KOOS) Pain Subscore on the KOOS Scoring System from baseline to 1-year post-operative is considered minimal perceptible clinical improvement and will be used to define the primary clinical success criterion for this study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bone Marrow Edema

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

BML of the Knee

Subject has single bone marrow lesion of tibia, single BML of femur, or adjoining BML's of tibia \& femur on which a Subchondroplasty procedure is performed

Subchondroplasty

Intervention Type PROCEDURE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Subchondroplasty

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Calcium Phosphate Bone substitute filling of micro fractures

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subject is 40-70 of age and skeletally mature
* Subject BMI is \< 40
* Subject has experienced pain in knee for at least 3 months
* BML is confirmed on T2 weighted MR Imaging by presence of white signal
* Subject has single BML of tibia, single BML of femur, or adjoining BML's of tibia \& femur
* Baseline KOOS pain subscore is ≤65
* Subject's involved knee alignment is defined radiographically as one of the following: Neutral, ≤ to 7 degrees mechanical varus or \< 7.5 degrees mechanical valgus
* Subject's ACL and PCL ligaments are intact
* Subject has failed no more than one operative treatment on treatment knee, and none within 6 months prior to enrollment
* Subject is willing and able to sign a written consent form
* The subject has the mental capacity and the willingness to comply with the specified follow-up evaluations, and can be contacted by telephone by the site personnel.

Exclusion Criteria

* Surgeon deems subject's pain to be primarily related to an alternate condition such as a baker cyst, synovitis, meniscal pathology, or other
* BML caused by acute trauma
* Subject is not neurologically intact (sensory, motor, and reflex deficit)
* Subject is insulin dependent
* Subject has a history of any invasive malignancy (except non-melanoma skin cancer), unless treated with curative intent and with no clinical signs or symptoms of the malignancy for 5 years
* Subject with primary bone tumor in the knee area
* Subject anticipates having a lower extremity surgery other than the investigational surgery during the course of the study
* Subject has a history of substance abuse
* Subject is currently involved in another study or have received investigational product or treatment within the last 30 days
* Subject is pregnant or planning on becoming pregnant during the study period
* Subject is accepting workers' compensation

Minimum Eligible Age

40 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No